Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This article evaluates what BPC-157 is, why it is biologically interesting, and where the evidence falls short when applied to real-world human healing
In pre-clinical models, BPC 157 has been observed to: Upregulate vascular endothelial growth factor (VEGF) , promoting new blood vessel formation in damaged tissue Modulate nitric oxide (NO) synthesis pathways, influencing vascular tone and healing cascades Interact with the growth hormone receptor system , potentially amplifying downstream tissue repair signaling Demonstrate cytoprotective effects along the gastrointestinal tract its native home territory as a gastric peptide Exhibit apparent neuroprotective properties in rodent models of CNS injury BPC 157 stability in gastric acid unusual for peptides has made it a focus of GI mucosal repair research
People with diabetes who were taking semaglutide were 45% less likely to be diagnosed with depression, and 44% less likely to have anxiety
Do not confuse with: E10.x Type 1 diabetes R73.9 Abnormal glucose (not yet diagnosed as diabetes) Z86.32 Personal history of gestational diabetes To view or add a comment, sign in More Relevant Posts Diabetic ketoacidosis (DKA) is a life-threatening diabetes complication where the body lacks enough insulin to use glucose for energy, causing it to break down fat, which produces toxic ketones that make the blood acidic
Celebrate small milestones to stay motivated
